Liste des médicaments et vaccins
| DESIGNATION | DCI | TITULAIRE AMM | PAYS D'ORIGINE | PGHT(FCFA) | N°AMM | DATE EXPIRATION AMM |
|---|---|---|---|---|---|---|
| HICAINE 2% Gel T/30 g | LIDOCAÏNE | MEDNEXT BIOTECH LIMITED | Inde | 1358 | AMM_2024_17458 | 2030-05-31 |
| FLAXOR 200mg+500mg Comprimé pelliculé B/10 | OFLOXACINE + ORNIDAZOLE | OXFORD LABORATORIES PVT. LTD. | Inde | 1771.08 | AMM_2022_14548 | 2030-05-31 |
| ERECTAD-20 20mg Comprimé pelliculé B/4 | TADALAFIL | ASMOH LABORATORIOES LTD. | Inde | 5903.61 | 10228/15 | 2030-05-31 |
| EPINORIN 2mg/mL Solution pour perfusion en ampoule B/10 | NOREPINEPHRINE | MYRA HEALTHCARE | Inde | 6559.57 | AMM_2024_18384 | 2030-05-31 |
| ENALAPRIL BIOGARAN 5mg Comprimé sécable B/28 | ENALAPRIL | BIOGARAN | France | 1351.27 | AMM_2024_17920 | 2030-05-31 |
| DOZOLE 20mg+30mg Gélule B/10 | RABEPRAZOLE + DOMPERIDONE | FIZA HEALTHCARE PVT. LTD. | Inde | 2033.47 | AMM_2023_16356 | 2030-05-31 |
| DOLUTEGRAVIR/LAMIVUDINE/FUMARATE DE TENOFOVIR DISOPROXIL 50mg+300mg+300mg Comprimé pelliculé B/90 | DOLUTEGRAVIR + LAMIVUDINE + FUMARATE DE TENOFOVIR DISOPROXIL | LAURUS LABS LIMITED | Inde | 22958.49 | AMM_2024_17313 | 2030-05-31 |
| DOLUTEGRAVIR/LAMIVUDINE/FUMARATE DE TENOFOVIR DISOPROXIL 50mg+300mg+300mg Comprimé pelliculé B/30 | DOLUTEGRAVIR + LAMIVUDINE + FUMARATE DE TENOFOVIR DISOPROXIL | LAURUS LABS LIMITED | Inde | 13119.14 | AMM_2024_17312 | 2030-05-31 |
| DOLUTEGRAVIR/LAMIVUDINE/FUMARATE DE TENOFOVIR DISOPROXIL 50mg+300mg+300mg Comprimé pelliculé B/180 | DOLUTEGRAVIR + LAMIVUDINE + FUMARATE DE TENOFOVIR DISOPROXIL | LAURUS LABS LIMITED | Inde | 32797.85 | AMM_2024_17314 | 2030-05-31 |
| DICLOCED 1mg/mL Collyre Fl/10 mL | DICLOFENAC | LABORATOIRES THEA | France | 2558.23 | AMM_2017_2304 | 2030-05-31 |
